BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

@article{LingfordHughes2012BAPUG,
  title={BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP},
  author={A. Lingford-Hughes and S. Welch and L. Peters and D. Nutt},
  journal={Journal of Psychopharmacology},
  year={2012},
  volume={26},
  pages={899 - 952}
}
  • A. Lingford-Hughes, S. Welch, +1 author D. Nutt
  • Published 2012
  • Medicine
  • Journal of Psychopharmacology
  • The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and… CONTINUE READING
    206 Citations
    Human pharmacology for addiction medicine: From evidence to clinical recommendations.
    • 12
    • Highly Influenced
    Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision
    • 30
    • PDF
    Canadian Guidelines on Opioid Use Disorder Among Older Adults
    • 1
    • PDF

    References

    SHOWING 1-10 OF 647 REFERENCES
    Adolescent substance abuse and psychiatric comorbidities.
    • D. Deas, E. Brown
    • Psychology, Medicine
    • The Journal of clinical psychiatry
    • 2006
    • 199
    • PDF
    Treating comorbid substance use disorders in schizophrenia
    • 43
    Psychosocial interventions for people with both severe mental illness and substance misuse.
    • 152
    • PDF
    Psychoactive drug abuse in older adults.
    • 240